Has Douglas Johnson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $704,207 in general payments to Douglas Johnson, MD across 1,381 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Douglas Johnson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Douglas Johnson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Douglas Johnson, MD

Dermatology · Honolulu, HINPI 1700869427

Payments from drug & device makers

$704,207in general payments, 2019–2025

Across 1,381 payments — averaging $509.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$159K
AbbVie$87K
Lilly USA, LLC$80K
UCB, Inc.$74K
Regeneron Healthcare Solutions, Inc.$66K
Novartis$47K
plus $192K from 22 others

What the payments were for

Consulting fees$46,3288%
Speaking & faculty fees$427,18675%
Grants$8,0001%
Travel & lodging$50,4819%
Food & beverage$36,1486%
Education$3360%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	50	$158,622
AbbVie	153	$86,827
Lilly USA, LLC	136	$80,367
UCB, Inc.	108	$73,885
Regeneron Healthcare Solutions, Inc.	126	$65,885
Novartis	151	$46,850
Pfizer	64	$43,097
Amgen	163	$41,317
Sun Pharmaceutical Industries Inc.	64	$20,273
Bristol Myers Squibb	22	$16,957
Galderma Laboratories, L.p.	38	$16,323
Sanofi	59	$16,150
E.r. Squibb & Sons, L.L.C.	60	$9,886
LEO Pharma Inc.	74	$8,891
Ortho Dermatologics, A Division Of Bausch Health US, LLC	30	$7,767
Dermira, Inc.	10	$5,879
Dermavant Sciences, Inc.	4	$2,813
Arcutis Biotherapeutics, Inc.	30	$1,049
Johnson & Johnson	18	$468
Genentech USA, Inc.	10	$202
Regeneron	1	$161
Sanofi US Services Inc.	1	$135
Sanofi-aventis U.S. LLC	2	$117
Almirall LLC	1	$97
Smith+Nephew	3	$69
Blueprint Medicines Corporation	1	$63
Organon	1	$31
ANI Pharmaceuticals, Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$86,504
Bimzelx$71,289
Otezla$49,518
COSENTYX$44,302
Skyrizi$42,772
CIBINQO$42,524
OLUMIANT$38,012
Rinvoq$31,374
EBGLYSS$26,016
OPZELURA$22,129
ILUMYA$19,077
Humira$12,012
ADBRY$7,680
SILIQ$7,383
QBREXZA$5,764
Enbrel$5,323
NEMLUVIO$5,066
VTAMA$2,719
Sotyktu$386
ZORYVE$375

How this compares

$704,207 in reported general payments places this provider in the 95th percentile of 67 dermatology providers in Hawaii.

See all dermatology providers in Hawaii →

Medicare billing

Part B allowed, 2024

$63,430

Medicare patients

221

Services billed

1,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Bimzelx AutoinjectorBimekizumab-Bkzx	12	$166,293
Dupixent SyringeDupilumab	41	$164,510
Cosentyx Sensoready (2 Pens)Secukinumab	11	$94,255
Tacrolimus	29	$5,596
Betamethasone Dipropionate	100	$4,993
Fluocinonide	85	$4,024
Clobetasol Propionate	33	$2,142
Alclometasone Dipropionate	45	$2,008
Ketoconazole	100	$1,780
MethotrexateMethotrexate Sodium	53	$1,632
Triamcinolone Acetonide	136	$1,475
Hydrocortisone	104	$1,282
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	26	$1,229
Halobetasol Propionate	21	$1,079
Fluorouracil	15	$1,069

Paid to pharmacies, not to this prescriber.

Other dermatology in Honolulu

Sarah HowellHonolulu$653K
Ryan SatoHonolulu$226K
Greg SakamotoHonolulu$20K
Kory KitagawaHonolulu$18K
Kevin DawsonHonolulu$16K
Dylan LeeHonolulu$15K
Sarah GrekinHonolulu$13K
Gregory HerbichHonolulu$12K
Shelbi Jim OnHonolulu$10K
Stella MatsudaHonolulu$9K

See the full list for Hawaii →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →